Hochschulschrift
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
33 Bl.
- Notes
-
Ill., graph. Darst.
Enth. 1 Sonderabdr. aus: The American Journal of Pathology ; Vol. 181, No. 2 (2012). - Text teilw. dt., teilw. engl.
Bonn, Univ., Diss., 2014
- Classification
-
Medizin, Gesundheit
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:25 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
Wild-type and mutated IDH1/2 enzymes and therapy responses
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
IDH1-dependent chemical alterations in gliomas, and its implications for in situ optical diagnosis
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner
The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas
Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
Wild-type and mutated IDH1/2 enzymes and therapy responses
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
IDH1-dependent chemical alterations in gliomas, and its implications for in situ optical diagnosis
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner
The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas
Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
Wild-type and mutated IDH1/2 enzymes and therapy responses
Methylation class oligosarcoma may encompass IDH-wildtype gliomas
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Surgery for IDH1/2 wild-type glioma invading the corpus callosum
Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas
IDH1-dependent chemical alterations in gliomas, and its implications for in situ optical diagnosis
Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner